Holen Sie sich die Stockscreener-App
0.00
100.00%
-14.49
Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten
BioMarin to buy rare disease drugmaker Amicus Therapeutics for $4.8B - MSN
MSN Money - MSN
BioMarin beats estimates, raises guidance on Amicus deal By Investing.com - Investing.com South Africa
BioMarin beats estimates, raises guidance on Amicus deal - Investing.com
BioMarin Reports First Quarter 2026 Financial and Operating Results - Santa Maria Times
UBS Group AG Grows Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
CM Management LLC Has $5.27 Million Stock Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
BioMarin acquires Amicus Therapeutics for $4.8bn - MSN
BioMarin Amicus Deal Expands Rare Disease Reach And Adds Kidney Asset - Sahm
Glazer Capital (FOLD) reports zero holdings after falling below 5% stake - Stock Titan
MSN - MSN
Pictet Asset Management Holding SA Trims Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Decreases Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
BioMarin Closes Amicus Deal As FOLD Delists And Indices Adjust - Sahm
[EFFECT] AMICUS THERAPEUTICS, INC. SEC Filing - Stock Titan
Amicus Therapeutics (FOLD) Expected to Announce Earnings on Thursday - MarketBeat
Amicus Therapeutics, Inc. Financial Disclosures & Filings - TradingView
Vanguard Capital Management holds 5.20% of Amicus Therapeutics (NASDAQ: FOLD) - Stock Titan
Amicus Therapeutics, Inc.(NasdaqGM: FOLD) dropped from S&P Global BMI Index - marketscreener.com
Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
BioMarin closes $4.8B Amicus deal to boost rare disease portfolio - MSN
Net current asset value per share of Amicus Therapeutics, Inc. – BIVA:FOLD - TradingView
Amicus Therapeutics Hits New 52-Week High at $14.50 - Markets Mojo
Amicus Therapeutics, Inc.(NasdaqGM: FOLD) dropped from Russell 3000E Growth Index - marketscreener.com
Amicus Therapeutics (NASDAQ: FOLD) director’s shares and options cashed out in BioMarin deal - Stock Titan
Amicus Therapeutics (FOLD) director cashes out stock and options in BioMarin deal - Stock Titan
BioMarin deal pays Amicus (NASDAQ: FOLD) director $14.50 per share - Stock Titan
Amicus Therapeutics (NASDAQ: FOLD) director cashes out equity in BioMarin deal - Stock Titan
Amicus Therapeutics (NASDAQ: FOLD) director equity paid out at $14.50 in BioMarin deal - Stock Titan
Director at Amicus (NASDAQ: FOLD) exits stake in BioMarin deal - Stock Titan
BioMarin-Amicus deal pays out Amicus (NASDAQ: FOLD) director - Stock Titan
BioMarin acquisition cashes out Amicus (FOLD) director’s shares and options - Stock Titan
Amicus Therapeutics (FOLD) CAO exits stock and options in BioMarin deal - Stock Titan
BioMarin-Amicus deal pays CDO Castelli (FOLD) $14.50 per share - Stock Titan
Amicus Therapeutics (FOLD) CPO equity fully cashed out at $14.50 deal price - Stock Titan
Amicus (FOLD) chief legal officer exits equity as BioMarin buyout pays $14.50 - Stock Titan
Amicus Therapeutics (FOLD) CFO exits equity as BioMarin acquisition closes - Stock Titan
Amicus Therapeutics (FOLD) CEO disposes 1.0M shares, options in BioMarin merger - Stock Titan
BioMarin completes $4.8B acquisition of Amicus Therapeutics - Investing.com UK
Amicus Therapeutics Q3 2025 Earnings Preview - MSN
[POS AM] AMICUS THERAPEUTICS, INC. SEC Filing - Stock Titan
Amicus Therapeutics (NASDAQ: FOLD) taken private in $14.50-per-share cash merger - Stock Titan
[POSASR] AMICUS THERAPEUTICS, INC. SEC Filing - Stock Titan
BioMarin Pharmaceutical Closes $4.8 Billion Acquisition of Amicus Therapeutics - marketscreener.com
BioMarin completes $4.8B acquisition of Amicus Therapeutics By Investing.com - Investing.com South Africa
Amicus Therapeutics withdraws Nasdaq listing | FOLD SEC FilingForm 25-NSE - Stock Titan
BioMarin Completes Amicus Acquisition, Expands Rare Disease Portfolio - TipRanks
BioMarin (NASDAQ: BMRN) adds Galafold and Pombiliti in Amicus deal - Stock Titan
BioMarin Completes Acquisition of Amicus Therapeutics - PR Newswire
CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD) - AOL.com
Amicus Therapeutics, Inc.(NasdaqGM: FOLD) dropped from NASDAQ Composite Index - marketscreener.com
CIBRA Capital Increases Amicus Therapeutics Holdings – April 2026 SEC FilingNews and Statistics - IndexBox
CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD) - The Motley Fool
Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And Rare Disease Growth Prospects - simplywall.st
Amicus Therapeutics stock hits 52-week high at $14.48 By Investing.com - Investing.com India
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):